A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of Xolair, (omalizumab) in peanut allergy (TOPS)
Sampson HA, Leung DYM, Burks W, Lack G, Bahma SL, Jones SM, Varshavsky J, Wong DA, Deniz Y, TOPS Study Group. A phase II, randomized, double-blind, parallel-group, placebo-controlled, oral food challenge trial of Xolair, (omalizumab) in peanut allergy (TOPS). J Allergy Clin Immunol. 2007; S117.